Giuseppe Bruno | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Modulation of the cannabinoid system. a new perspective for the treatment of the Alzheimer's disease	CURRENT NEUROPHARMACOLOGY	2018
Migrants seeking help for cognitive disturbances. exploratory data from an Italian memory clinic	NEUROLOGICAL SCIENCES	2018
Baseline assessment of physical frailty in neurological drug development	CNS NEUROSCIENCE & THERAPEUTICS	2018
Agreement between diseases-centered and multidimensional models of care in disadvantaged settings	EUROPEAN JOURNAL OF INTERNAL MEDICINE	2018
Estimating dementia cases in the immigrant population living in italy	NEUROLOGICAL SCIENCES	2018
The italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design	NEUROLOGICAL SCIENCES	2017
Sex and gender differences in the treatment of Alzheimer's disease: A systematic review of randomized controlled trials	PHARMACOLOGICAL RESEARCH	2017
Why Mild Cognitive Impairment Should Not Be Approached as a Disease: Reply to Iraqi and Hughes	JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION	2017
Promoting the assessment of frailty in the clinical approach to cognitive disorders	FRONTIERS IN AGING NEUROSCIENCE	2017
Inappropriate Sexual Behaviors Among Community-Dwelling Patients with Dementia	AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY	2017
Disease progression in mild dementia due to Alzheimer disease in an 18-month observational study (GERAS): the impact on costs and caregiver outcomes	DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. EXTRA	2017
The sterile controversy on the amyloid cascade hypothesis	NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS	2017
External validity of randomized controlled trials on Alzheimer's disease: the biases of frailty and biological aging	FRONTIERS IN NEUROLOGY	2017
Need to recalibrate research outcomes in Alzheimer's disease. focus on neuropsychiatric symptoms	JOURNAL OF THE AMERICAN GERIATRICS SOCIETY	2017
How useful is the eq-5d in assessing the impact of caring for people with Alzheimer's disease?	HEALTH AND QUALITY OF LIFE OUTCOMES	2017
What Drives Country Differences in Cost of Alzheimer's Disease? An Explanation from Resource Use in the GERAS Study.	JOURNAL OF ALZHEIMER'S DISEASE	2017
The impact of frailty on the risk of conversion from mild cognitive impairment to Alzheimer’s disease: evidences from a five-year observational study	FRONTIERS IN MEDICINE	2017
Nutrition and dementia: Evidence for preventive approaches?	NUTRIENTS	2016
Are we really tackling the evidence-based medicine issue in alzheimer's disease	EUROPEAN JOURNAL OF INTERNAL MEDICINE	2016
Spontaneous Reversion of Mild Cognitive Impairment to Normal Cognition: A Systematic Review of Literature and Meta-Analysis	JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION	2016

ERC

LS5_11

Interessi di ricerca

Neurologia cognitiva; epidemiologia, genetica, clinica e neurofarmacologia della malattia di Alzheimer e altre demenze e delle malattie extrapiramidali con particolare riferimento alla sperimentazione di nuove procedure diagnostiche e terapeutiche (studi di neurofarmacologia clinica di fase 2-3-4) disturbi neuropsichiatrici; prevenzione dei disturbi cognitivi; nuove metodiche di somministrazione farmacologica e relative strategie terapeutiche in accordo con GCP.